US Bancorp
BMRA icon

US Bancorp’s Biomerica BMRA Stock Holding History

US Bancorp’s Portfolio BMRA Stock Details BMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-6
Closed -$22 – 4089
2024
Q2 		$22 Buy
+6
New +$31 ﹤0.01% 3952

Other funds holding BMRA

GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
FC
Fore Capital New York $162M AUM 14.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

US Bancorp's BMRA Position: Q3 2024 in Review

US Bancorp sold out of Biomerica (BMRA) in Q3 2024, closing a stake of 6 shares — an estimated $22 sold.

US Bancorp first reported a position in BMRA in Q2 2024 and held it in 1 quarter. The position peaked at $22 in Q2 2024. 25 funds tracked by Wall St. Rank hold BMRA as of Q3 2024.

  • US Bancorp reported no remaining Biomerica position as of Q3 2024 after selling out during the quarter.
  • US Bancorp sold 6 Biomerica shares in Q3 2024, an estimated $22.
  • US Bancorp first reported a position in Biomerica in Q2 2024 and held it in 1 quarter.
  • US Bancorp's Biomerica position peaked at $22 in Q2 2024.
  • 25 funds tracked by Wall St. Rank held Biomerica as of Q3 2024.

Based on US Bancorp's 13F filing for Q3 2024, filed 28 Oct 2024.